MXPA05004966A - Derivados cristalinos de canabinoide y procesos de purificacion de canabinoide. - Google Patents

Derivados cristalinos de canabinoide y procesos de purificacion de canabinoide.

Info

Publication number
MXPA05004966A
MXPA05004966A MXPA05004966A MXPA05004966A MXPA05004966A MX PA05004966 A MXPA05004966 A MX PA05004966A MX PA05004966 A MXPA05004966 A MX PA05004966A MX PA05004966 A MXPA05004966 A MX PA05004966A MX PA05004966 A MXPA05004966 A MX PA05004966A
Authority
MX
Mexico
Prior art keywords
cannabinoid
aryl
process according
sulfonate
benzene
Prior art date
Application number
MXPA05004966A
Other languages
English (en)
Spanish (es)
Inventor
R Duchek John
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of MXPA05004966A publication Critical patent/MXPA05004966A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
MXPA05004966A 2002-11-12 2003-11-06 Derivados cristalinos de canabinoide y procesos de purificacion de canabinoide. MXPA05004966A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42554302P 2002-11-12 2002-11-12
US43502702P 2002-12-20 2002-12-20
PCT/US2003/035599 WO2004043946A1 (en) 2002-11-12 2003-11-06 Cannabinoid crystalline derivatives and process of cannabinoid purification

Publications (1)

Publication Number Publication Date
MXPA05004966A true MXPA05004966A (es) 2005-08-02

Family

ID=32314593

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05004966A MXPA05004966A (es) 2002-11-12 2003-11-06 Derivados cristalinos de canabinoide y procesos de purificacion de canabinoide.

Country Status (13)

Country Link
US (1) US7402686B2 (enExample)
EP (1) EP1560819B1 (enExample)
JP (1) JP2006508132A (enExample)
AT (1) ATE410419T1 (enExample)
AU (1) AU2003287585B2 (enExample)
CA (1) CA2504743C (enExample)
DE (1) DE60324011D1 (enExample)
DK (1) DK1560819T3 (enExample)
ES (1) ES2315548T3 (enExample)
MX (1) MXPA05004966A (enExample)
PT (1) PT1560819E (enExample)
SI (1) SI1560819T1 (enExample)
WO (1) WO2004043946A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
WO2006007734A1 (de) * 2004-07-19 2006-01-26 Cilag Ltd. Verfahren zur gewinnung von reinem tetrahydrocannabinol
EA200701246A1 (ru) * 2004-12-09 2008-06-30 Инсис Терапьютикс, Инк. Стабильные при комнатной температуре составы дронабинола
AU2012201041B2 (en) * 2005-09-29 2012-12-06 Albany Molecular Research, Inc. Process for production of delta-9-tetrahydrocannabinol
EP2578577A1 (en) * 2005-09-29 2013-04-10 Albany Molecular Research, Inc. Sulfonyl esters of tetrahydrocannabinol and derivatives thereof
CA2659775A1 (en) * 2006-08-04 2008-02-14 Insys Therapeutics Inc. Aqueous dronabinol formulations
GB0702895D0 (en) * 2007-02-14 2007-03-28 Resolution Chemicals Ltd Delta 9 tetrahydrocannabinol derivatives
GB0703284D0 (en) 2007-02-20 2007-03-28 Resolution Chemicals Ltd Delta 9 - tetrahydrocannabinol processing
CA2698752A1 (en) * 2007-08-06 2009-02-12 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
WO2009099868A1 (en) * 2008-02-06 2009-08-13 Mallinckrodt Inc. Process for the preparation of (-) -delta 9-tetrahydrocannabinol
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US9539295B2 (en) 2014-12-05 2017-01-10 Bradley Michael Bohus Cannabidiol (CBD) enriched alcohol
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
GB201910389D0 (en) * 2019-07-19 2019-09-04 Gw Pharma Ltd Novel compounds, methods for their manufacture, and uses thereof
US11925907B2 (en) 2019-07-22 2024-03-12 Canopy Growth Corporation Continuous crystallization of cannabinoids in a stirred-tank reactor
WO2021055079A1 (en) 2019-09-16 2021-03-25 Vapor Cartridge Technology Llc Drug delivery system with stackable substrates
JP2023512578A (ja) * 2020-02-06 2023-03-27 ロンドン ファーマシューティカルズ アンド リサーチ コーポレーション Ｃアナビンオイド硫酸エステル、その塩及び用途
AU2022362107A1 (en) * 2021-10-11 2024-05-02 Anebulo Pharmaceuticals, Inc. Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507888A (en) 1966-08-30 1970-04-21 Searle & Co Process and intermediates for manufacture of 17-oxygenated estr-4-en-3-ones
US3728360A (en) 1971-08-31 1973-04-17 Little Inc A Ester derivatives of tetrahydrocannabinol
US4188495A (en) 1977-11-14 1980-02-12 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
US4206225A (en) 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4341906A (en) 1979-09-24 1982-07-27 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes
US4381399A (en) 1981-12-21 1983-04-26 Aerojet-General Corporation Purification of tetrahydrodibenzo[b,d]pyrans from crude synthetic mixtures
GB9303911D0 (en) 1993-02-26 1993-04-14 Zeneca Ltd Chemical process
JP3384163B2 (ja) * 1994-11-09 2003-03-10 株式会社ニコン 顕微鏡対物レンズ
US6008383A (en) 1998-10-26 1999-12-28 University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol esters
WO2006000734A1 (en) 2004-06-23 2006-01-05 Bp P.L.C. The synthesis of the micro-porous silica gel and its application to the preparation of catalysts for c2 oxygenates synthesis from syngas

Also Published As

Publication number Publication date
AU2003287585A1 (en) 2004-06-03
EP1560819B1 (en) 2008-10-08
EP1560819A1 (en) 2005-08-10
PT1560819E (pt) 2008-11-03
WO2004043946A1 (en) 2004-05-27
ES2315548T3 (es) 2009-04-01
SI1560819T1 (sl) 2009-06-30
JP2006508132A (ja) 2006-03-09
US7402686B2 (en) 2008-07-22
DK1560819T3 (da) 2009-02-09
ATE410419T1 (de) 2008-10-15
AU2003287585B2 (en) 2009-05-07
US20060094774A1 (en) 2006-05-04
CA2504743A1 (en) 2004-05-27
DE60324011D1 (de) 2008-11-20
CA2504743C (en) 2012-04-24

Similar Documents

Publication Publication Date Title
MXPA05004966A (es) Derivados cristalinos de canabinoide y procesos de purificacion de canabinoide.
CA2751741C (en) Process for the preparation of (-) -delta 9-tetrahydrocannabinol
CA2623723A1 (en) Process for production of delta-9-tetrahydrocannabinol
ES2350031T3 (es) Procedimiento para la preparación de derivados de ácido trans-4-amino-1-ciclohexanocarboxílico.
US7321064B1 (en) Preparation of amides of retinoic acid via mixed anhydride and mixed carbonate intermediates
KR20040010720A (ko) 피페리딘 유도체 펙소페나딘의 제조방법
CN108586399B (zh) 一种非罗考昔的合成方法
CA2770448C (en) Cannabinoid esters
JPS6354365A (ja) ２−アミノ−４，６−置換ピリミジンの製造方法
FI67851C (fi) Foerfarande foer framstaellning av nya dopaminagonistiskt verkande benso(4,5)pyrano(2,3c)pyrrolderivat
KR100743278B1 (ko) 9-시스 레티노산의 제조 방법
KR101041551B1 (ko) 아리피프라졸 제조를 위해 유용한 신규 중간체와 신규중간체 및 아리피프라졸 제조 방법
JPH0742269B2 (ja) ４−アルコキシ−３−ピロリン−２−オン−１−イル−酢酸アルキルエステルおよびその製造方法
Toyota et al. Absolute Conformation and Chiroptical Properties. VI. 2, 2', 3, 3'-Tetramethoxy-9, 9'-bitriptycyl: A Stereochemical Analog of 1, 2-Disubstituted Ethane with Identical Substituents.
CN115557958B (zh) 一种制备生物素中间体光学活性内酯的方法
CN111848419B (zh) (e)-4-羟基-3-甲基-2-丁烯基胺及玉米素的合成方法
CN101356158B (zh) 用于制备孟鲁司特的中间体及相关的化合物
WO2024251276A1 (zh) 氧代吡啶类化合物的新型制备方法及关键中间体和应用
KR100501993B1 (ko) 페닐프로피온산 유도체 또는 그의 염의 제조방법
US6232471B1 (en) Synthesis of anti-inflammatory [1,2,3]triazoles
KR20000051844A (ko) 페닐프로피온산 유도체 또는 그의 염의 제조방법
CA2149988A1 (en) Synthesis of benzoquinolinones
JPH0413674A (ja) ジヒドロフラノン誘導体の製造方法
JPS59157052A (ja) 新規なナフチルエチルアミン誘導体
BRPI0806402A2 (pt) processo e composto

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights